First Capital Advisors Group’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

First Capital Advisors Group’s Portfolio PBE Stock Details PBE Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$213K	Hold
2023 Q1	$218K	Hold
2022 Q4	$221K	Hold
2022 Q3	$205K	Hold
2022 Q2	$201K	Buy
2018 Q4	–	Sell
2018 Q3	$207K	Buy
2018 Q2	–	Sell
2018 Q1	$171K	Buy